| DINACICLIB | Small molecule | multiple myeloma | Cyclin-dependent kinase 9 inhibitor | 2.0 | Completed | ClinicalTrials |
| SELICICLIB | Small molecule | breast cancer | Cyclin-dependent kinase 9 inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| DINACICLIB | Small molecule | acute lymphoblastic leukemia | Cyclin-dependent kinase 9 inhibitor | 2.0 | Terminated | ClinicalTrials |
| ALVOCIDIB | Small molecule | neoplasm | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | chronic lymphocytic leukemia | Cyclin-dependent kinase 9 inhibitor | 1.0 | Terminated | ClinicalTrials |
| RONICICLIB | Small molecule | small cell lung carcinoma | Cyclin-dependent kinase inhibitor | 2.0 | Terminated | ClinicalTrials |
| ALVOCIDIB | Small molecule | Mantle cell lymphoma | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | endometrial cancer | Cyclin-dependent kinase 9 inhibitor | 2.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | prostate cancer | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| DINACICLIB | Small molecule | acute myeloid leukemia | Cyclin-dependent kinase 9 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| SELICICLIB | Small molecule | non-small cell lung carcinoma | Cyclin-dependent kinase 9 inhibitor | 2.0 | Terminated | ClinicalTrials |
| ALVOCIDIB | Small molecule | nodal marginal zone B-cell lymphoma | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | chronic lymphocytic leukemia | Cyclin-dependent kinase 9 inhibitor | 2.0 | Terminated | ClinicalTrials |
| ALVOCIDIB | Small molecule | Waldenstrom macroglobulinemia | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | pancreatic adenocarcinoma | Cyclin-dependent kinase 9 inhibitor | 2.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | prolymphocytic leukemia | Cyclin-dependent kinase 9 inhibitor | 2.0 | Terminated | ClinicalTrials |
| BMS-387032 | Small molecule | multiple myeloma | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| RONICICLIB | Small molecule | neoplasm | Cyclin-dependent kinase inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | MALT lymphoma | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| PHA-793887 | Small molecule | neoplasm | Cyclin-dependent kinase inhibitor | 1.0 | Terminated | ClinicalTrials |
| BMS-387032 | Small molecule | chronic lymphocytic leukemia | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | sarcoma | Cyclin-dependent kinase 9 inhibitor | 2.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | esophageal cancer | Cyclin-dependent kinase 9 inhibitor | 2.0 | Completed | ClinicalTrials |
| DINACICLIB | Small molecule | chronic lymphocytic leukemia | Cyclin-dependent kinase 9 inhibitor | 3.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | adult acute lymphoblastic leukemia | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | multiple myeloma | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | kidney cancer | Cyclin-dependent kinase 9 inhibitor | 2.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | liver cancer | Cyclin-dependent kinase 9 inhibitor | 2.0 | Completed | ClinicalTrials |
| DINACICLIB | Small molecule | lentigo maligna melanoma | Cyclin-dependent kinase 9 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| ALVOCIDIB | Small molecule | Splenic Marginal Zone Lymphoma | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| AT-7519 | Small molecule | chronic lymphocytic leukemia | Cyclin-dependent kinase inhibitor | 2.0 | Completed | ClinicalTrials |
| DINACICLIB | Small molecule | neoplasm | Cyclin-dependent kinase 9 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| ALVOCIDIB | Small molecule | pancreatic adenocarcinoma | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | leukemia | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| RONICICLIB | Small molecule | small cell lung carcinoma | Cyclin-dependent kinase inhibitor | 1.0 | Terminated | ClinicalTrials |
| ALVOCIDIB | Small molecule | male breast carcinoma | Cyclin-dependent kinase 9 inhibitor | 1.0 | Terminated | ClinicalTrials |
| ZOTIRACICLIB | Small molecule | chronic lymphocytic leukemia | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| DINACICLIB | Small molecule | chronic lymphocytic leukemia | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | small intestine cancer | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| DINACICLIB | Small molecule | multiple myeloma | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| DINACICLIB | Small molecule | acral lentiginous melanoma | Cyclin-dependent kinase 9 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| ALVOCIDIB | Small molecule | myelodysplastic syndrome | Cyclin-dependent kinase 9 inhibitor | 1.0 | Terminated | ClinicalTrials |
| DINACICLIB | Small molecule | mucosal melanoma | Cyclin-dependent kinase 9 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| ALVOCIDIB | Small molecule | neoplasm | Cyclin-dependent kinase 9 inhibitor | 1.0 | Terminated | ClinicalTrials |
| ALVOCIDIB | Small molecule | lymphoid neoplasm | Cyclin-dependent kinase 9 inhibitor | 1.0 | Terminated | ClinicalTrials |
| SELICICLIB | Small molecule | pituitary-dependent Cushing's disease | Cyclin-dependent kinase 9 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| RONICICLIB | Small molecule | non-small cell lung carcinoma | Cyclin-dependent kinase inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| RGB-286638 | Small molecule | lymphoid neoplasm | Cyclin-dependent kinase 9 inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| ZOTIRACICLIB | Small molecule | rectum cancer | Cyclin-dependent kinase 9 inhibitor | 1.0 | Terminated | ClinicalTrials |
| ALVOCIDIB | Small molecule | follicular lymphoma | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| SELICICLIB | Small molecule | pituitary-dependent Cushing's disease | Cyclin-dependent kinase 9 inhibitor | 2.0 | Terminated | ClinicalTrials |
| ALVOCIDIB | Small molecule | lymphoma | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | breast cancer | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| DINACICLIB | Small molecule | melanoma | Cyclin-dependent kinase 9 inhibitor | 1.0 | Terminated | ClinicalTrials |
| BMS-387032 | Small molecule | neoplasm | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| AZD-5438 | Small molecule | neoplasm | Cyclin-dependent kinase inhibitor | 1.0 | Completed | ClinicalTrials |
| DINACICLIB | Small molecule | acute myeloid leukemia | Cyclin-dependent kinase 9 inhibitor | 2.0 | Terminated | ClinicalTrials |
| SELICICLIB | Small molecule | neoplasm | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| RONICICLIB | Small molecule | neoplasm | Cyclin-dependent kinase inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| BMS-387032 | Small molecule | Mantle cell lymphoma | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| DINACICLIB | Small molecule | breast cancer | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | chronic lymphocytic leukemia | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | cutaneous melanoma | Cyclin-dependent kinase 9 inhibitor | 2.0 | Completed | ClinicalTrials |
| AT-7519 | Small molecule | neoplasm | Cyclin-dependent kinase inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| ZOTIRACICLIB | Small molecule | hepatocellular carcinoma | Cyclin-dependent kinase 9 inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| ALVOCIDIB | Small molecule | acute myeloid leukemia | Cyclin-dependent kinase 9 inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| AT-7519 | Small molecule | multiple myeloma | Cyclin-dependent kinase inhibitor | 1.0 | Completed | ClinicalTrials |
| SELICICLIB | Small molecule | cystic fibrosis | Cyclin-dependent kinase 9 inhibitor | 2.0 | Terminated | ClinicalTrials |
| ZOTIRACICLIB | Small molecule | glioblastoma multiforme | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| ZOTIRACICLIB | Small molecule | gliosarcoma | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | prolymphocytic leukemia | Cyclin-dependent kinase 9 inhibitor | 1.0 | Terminated | ClinicalTrials |
| ALVOCIDIB | Small molecule | chronic lymphocytic leukemia | Cyclin-dependent kinase 9 inhibitor | 2.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | multiple myeloma | Cyclin-dependent kinase 9 inhibitor | 2.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | diffuse large B-cell lymphoma | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | acute myeloid leukemia | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| DINACICLIB | Small molecule | prolymphocytic leukemia | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | prostate cancer | Cyclin-dependent kinase 9 inhibitor | 2.0 | Completed | ClinicalTrials |
| AT-7519 | Small molecule | lymphoma | Cyclin-dependent kinase inhibitor | 1.0 | Completed | ClinicalTrials |
| DINACICLIB | Small molecule | pancreatic adenocarcinoma | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | cutaneous melanoma | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | acute myeloid leukemia | Cyclin-dependent kinase 9 inhibitor | 2.0 | Terminated | ClinicalTrials |
| DINACICLIB | Small molecule | male breast carcinoma | Cyclin-dependent kinase 9 inhibitor | 1.0 | Completed | ClinicalTrials |
| AT-7519 | Small molecule | Mantle cell lymphoma | Cyclin-dependent kinase inhibitor | 2.0 | Completed | ClinicalTrials |
| ALVOCIDIB | Small molecule | lymphoma | Cyclin-dependent kinase 9 inhibitor | 2.0 | Completed | ClinicalTrials |